AWM
IDXX icon

Axxcess Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Axxcess Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$576K Buy
+1,095
New +$614K 0.01% 679
2026
Q1 		– Sell
-1,707
Closed -$1.15M – 678
2025
Q4 		$1.15M Buy
1,707
+465
+37% +$317K 0.02% 481
2025
Q3 		$794K Sell
1,242
-869
-41% -$527K 0.02% 499
2025
Q2 		$1.13M Sell
2,111
-552
-21% -$264K 0.03% 398
2025
Q1 		$1.12M Buy
2,663
+273
+11% +$119K 0.03% 366
2024
Q4 		$988K Sell
2,390
-440
-16% -$193K 0.02% 404
2024
Q3 		$1.43M Sell
2,830
-29
-1% -$14.1K 0.04% 322
2024
Q2 		$1.39M Buy
2,859
+464
+19% +$233K 0.04% 317
2024
Q1 		$1.29M Sell
2,395
-1,370
-36% -$749K 0.04% 325
2023
Q4 		$2.09M Buy
+3,765
New +$1.77M 0.06% 240
2022
Q2 		– Sell
-550
Closed -$301K – 597
2022
Q1 		$301K Sell
550
-10,269
-95% -$5.4M 0.02% 473
2021
Q4 		$7.12M Buy
+10,819
New +$6.79M 0.52% 41

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Axxcess Wealth Management's IDXX Position: Q2 2026 in Review

Axxcess Wealth Management opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 1,095 shares worth $576K. The stake represents 0.01% of the portfolio and ranks #679 among its holdings. This is a return to the name: Axxcess Wealth Management previously reported a position in IDXX as recently as Q4 2025.

Axxcess Wealth Management first reported a position in IDXX in Q4 2021 and has held it in 12 quarters since. The position peaked at $7.12M in Q4 2021. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Axxcess Wealth Management held 1,095 shares of Idexx Laboratories worth $576K as of Q2 2026.
  • Idexx Laboratories was a new Axxcess Wealth Management position in Q2 2026.
  • Idexx Laboratories made up 0.01% of Axxcess Wealth Management's portfolio in Q2 2026, its #679 holding.
  • Axxcess Wealth Management first reported a position in Idexx Laboratories in Q4 2021 and has held it in 12 quarters since.
  • Axxcess Wealth Management's Idexx Laboratories position peaked at $7.12M in Q4 2021.
  • 1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Axxcess Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.